References
- Igarashi H. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24:9–160
- Peng H, Yin J, Ji W. Uninflammatory rhinogenic headache. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2006;13:495–7.
- Wang J, Yin J. Treatment of mucosal contact point headache by nassal endoscopy. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2011;18:307–10.
- Muñoz M, Coveñas R. Involvement of substance P and the NK-1 receptor in human pathology. Amino Acids 2014;7:1727–50.
- Qian M, Wu G, Zhu R, Zhang X. Development of the revised Eysenck personality questionnaire short scale for Chinese (EPQ-RSC). Xin Li Xue Bao 2000;32:317–23.
- Wang J, Yin J, Li J, Yang L, Duan Y. Clinical observation on relation between nasal mucosa contact point and headache. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2012;47:317–20.
- Abu-Bakra M, Jones NS. Does stimulation of nasal mucosa cause referred pain to the face? Clin Otolaryngol Allied Sci 2001;26:430–2.
- Ebner K, Singewald N. The role of substance P in stress and anxiety responses. Amino Acids 2006;31:251–72.
- Sartori KE, Nicolas SBS. Tachykinin receptors as therapeutic targets in stress-related disorders. Curr Pharm Des 2009;15:1647–74.
- Muñoz M, Coveñas R. Involvement of substance P and the NK-1 receptor in cancer progression. Peptides 2013;48:1–9.
- Sharp SI, McQuillin A, Marks M, Hunt SP, Stanford SC, Lydall GJ, et al. Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome. Am J Med Genet B Neuropsychiatr Genet 2014;165:373–80.
- Brown DC, Agnello K. Intrathecal substance P-saporin in the dog: efficacy in bone cancer pain. Anesthesiology 2013;119:1178–85.
- Uematsu T, Sakai A, Ito H, Suzuki H. Intra-articular administration of tachykinin NK 1 receptor antagonists reduces hyperalgesia and cartilage destruction in the inflammatory joint in rats with adjuvant-induced arthritis. Eur J Pharmacol 2011;668:163–8.
- Zheng XF, Li B, Zhang YH, Yang YH, Meng XY, Jiang SD, et al. Blockade of substance P receptor attenuates osteoporotic pain, but not bone loss, in ovariectomized mice. Menopause 2013;20: 1074–83.
- Zhang H, Liu LM, Lu GS, Xiong EQ, Li WB, Zhou ZS, et al. [Correlation between activation of L5-S2 spinal cord astrocytes and effect of substance P in chronic prostatitis pain]. Zhonghua Nan Ke Xue 2009;15:1021–7.
- Blumenthal HJ. Headaches and sinus disease. Headache 2001;41: 883–8.
- Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 1998;392:390–4.
- Welge-Luessen A, Hauser R, Schmid N, Kappos L, Probst R. Endonasal surgery for contact point headaches: a 10-year longitudinal study. Laryngoscope 2003;113:2151–6.